11/14/2012 Researchers at the National Cancer Institute have discovered a new way in which PARP inhibitors block cancer cell growth. They also discovered that three experimental PARP inhibitors vary widely … Continued
A study conducted by the Centers for Disease Control and Prevention showed that women were not aware of the non-gynecologic symptoms of gynecologic cancers, such as abdominal or back pain. … Continued
11/09/2012 A study by researchers at the Herbert Irving Comprehensive Cancer Center (HICCC) at NewYork-Presbyterian/Columbia University Medical Center, recently e-published ahead of print by the Journal of Clinical Oncology, suggests that women who … Continued
This morning the Ovarian Cancer National Alliance sent a letter to President Obama congratulating him on his re-election and outlining some of our policy priorities for his second term. Click … Continued
11/05/2012 In an article published in Cancer Prevention Research, a group of researchers in Australia examined the relationship between lifetime exposure to solar ultraviolet radiation (UVR) and ovarian cancer. The … Continued
11/02/2012 In a study published in the journal Cancer Epidemiology, Australian researchers examined the relationship between tea drinking and the risk of ovarian cancer among southern Chinese women. The study, … Continued
As an avid outdoorswoman and an ovarian cancer survivor, Sean Patrick saw connections between both sides of her life. She once said: “The skills women learn in climbing—problem solving, risk … Continued
10/29/2012 Research published in Cancer Epidemiology, Biomarkers, and Prevention shows that type II diabetes mellitus was not associated with risk of epithelial ovarian cancer. The risk ration was higher for … Continued
The National Comprehensive Cancer Network (NCCN) released new guidelines on palliative care for cancer patients. “The guidelines outline procedures for screening, assessment, palliative care interventions, reassessment, and after-death care.”
Michelle Andrews of Kaiser Health News talks about health insurance companies’ coverage of chemotherapy. Watch the clip here.
A new study indicates that the stiffness of an ovarian cancer cell can indicate whether or not it is likely to be metastatic: the more stiff the cell is, the … Continued
Dr. Ruprecht Wiedemeyer is a 2012 Liz Tilberis Grantee. In this interview with OCRF's Sarah DeFeo, Dr. Wiedemeyer discusses his research and what it means to receive a grant from OCRF.
Get email updates about research news, action alerts, and ways to join the fight.
